Announcements Trials
Browse Landscape

Phase

Phase NA 15Phase 3 3Phase 4 1Phase 2 1

Status

Unknown 1Terminated 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Cholangiocarcinoma 2Pancreatic Neoplasms 1Neoplasms 1

Interventions

Cisplatin 726Carboplatin 609Paclitaxel 579Cyclophosphamide 516Radiotherapy 511Docetaxel 477Fluorouracil 454Gemcitabine 438Doxorubicin 383Capecitabine 361Dexamethasone 328Oxaliplatin 289pembrolizumab 283Leucovorin 283Bevacizumab 275Etoposide 272Vincristine 270Rituximab 246Prednisone 223Pemetrexed 217Cytarabine 205Drug Therapy 194Trastuzumab 176Irinotecan 174Methotrexate 171Lenalidomide 137Nivolumab 136Filgrastim 135Epirubicin 129Tamoxifen 128

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Cholangiopancreatography, Endoscopic Retrograde × Clear all
NCT02340728 2020-10-22

Endoscopic Biliary Co-axial Stent Placement Plus/Minus Use of Radiofrequency Ablation (RFA) for Clearance of Occluded Self Expandable Metal Stents (SEMS) in Patients With Distal Biliary Obstruction From Unresectable Biliary-pancreatic Malignancies

Memorial Sloan Kettering Cancer Center

Phase 3 Completed
24 enrolled 9 charts
Gastrointestinal

Pancreatic Neoplasms

NCT00907413 2015-06-03

PDT

Weill Medical College of Cornell University

Phase 3 Terminated
50 enrolled
Gastrointestinal

Neoplasms, Cholangiocarcinoma

NCT00653978 2011-06-22

Unilateral Versus Bilateral Stents for Bismuth Type II and III Malignant Hilar Strictures

Changhai Hospital

Phase 3 Unknown
150 enrolled
Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡